Stay updated on Tisotumab Vedotin Efficacy in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Tisotumab Vedotin Efficacy in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tisotumab Vedotin Efficacy in Solid Tumors Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page has been updated to reflect the inclusion of Seagen as a subsidiary of Pfizer, along with new dates related to upcoming events. The previous mention of the Medical Monitor has been removed.
    Difference
    1%
    Check dated 2025-03-25T14:11:14.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The webpage has updated its date-related content, adding several new dates for 2025 and 2026 while removing some previous dates.
    Difference
    0.6%
    Check dated 2025-03-11T04:38:11.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.9%
    Check dated 2025-02-24T20:58:45.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The webpage now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.
    Difference
    0.9%
    Check dated 2025-02-10T09:49:15.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.1 to 2.14.2.
    Difference
    0.1%
    Check dated 2025-02-03T08:25:25.000Z thumbnail image
  8. Check
    67 days ago
    Change Detected
    Summary
    The website has transitioned from a recruiting status to 'Active, not recruiting', with the latest update on January 14, 2025, while numerous principal investigators and their contact details have been removed.
    Difference
    13%
    Check dated 2025-01-19T22:15:24.000Z thumbnail image

Stay in the know with updates to Tisotumab Vedotin Efficacy in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tisotumab Vedotin Efficacy in Solid Tumors Clinical Trial page.